Joylux Adds $5.5M in Series A Funding to Expand Its Menopause Platform; Announces Collaboration with Essity
Summary
Menopause company Joylux closed on $5.5M in new commitments from notable Silicon Valley investors J-Ventures, J-Impact and Dr. Kathy Fields, bringing their total Series A round to $13M. Utilizing red-light LEDs and gentle heat, their patented and clinically-validated technology rebuilds collagen and elastin and increases blood flow in the vaginal tissue, resulting in dramatic improvement in GSM symptomsless bladder leakage and vaginal dryness and improved sexual functionin less than 8 weeks. In 2021, Joylux app-enabled the devices to provide personalized treatment plans, rich educational content, and community connection with other women struggling with these changes. Joylux devices and accessory products are now carried by over 1,000 medical professionals and retail partners such as Saks.com, Goop, and Neiman Marcus in the United States, Canada and the United Kingdom.Colette Courtion, Joylux Founder & CEO shares: We are making aggressive moves to capitalize on the enormous market opportunity and health needs that menopause brings. Women want alternative treatment options to hormone replacement therapy, and we now have a platform of products that address a myriad of menopause health issues with non-hormonal solutions.
Funding
Classifications
AskAI Classifications
LabelsLinked Companies
